Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain. They are tetrameric complexes composed of glycine-binding GluN1 and GluN3 subunits together with glutamate-binding GluN2 subunits. Subunit-selective antagonists that discriminate between the glycine sites of GluN1 and GluN3 subunits would be valuable pharmacological tools for studies on the function and physiological roles of NMDA receptor subtypes. In a virtual screening for antagonists that exploit differences in the orthosteric binding site of GluN1 and GluN3 subunits, we identified a novel glycine site antagonist, 1-thioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (TK40). Here, we show by Schild analysis that TK40 is a potent competitive antagonist with Kb values of 21-63 nM at the GluN1 glycine-binding site of the four recombinant GluN1/N2A-D receptors. In addition, TK40 displayed >100-fold selectivity for GluN1/N2 NMDA receptors over GluN3A- and GluN3B-containing NMDA receptors and no appreciable effects at AMPA receptors. Binding experiments on rat brain membranes and the purified GluN1 ligand-binding domain using glycine site GluN1 radioligands further confirmed the competitive interaction and high potency. To delineate the binding mechanism, we have solved the crystal structure of the GluN1 ligand-binding domain in complex with TK40 and show that TK40 binds to the orthosteric binding site of the GluN1 subunit with a binding mode that was also predicted by virtual screening. Furthermore, the structure reveals that the imino acetamido group of TK40 acts as an α-amino acid bioisostere, which could be of importance in bioisosteric replacement strategies for future ligand design.
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010, Pubmed
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010,
Pubmed ARUNLAKSHANA,
Some quantitative uses of drug antagonists.
1959,
Pubmed Awobuluyi,
Subunit-specific roles of glycine-binding domains in activation of NR1/NR3 N-methyl-D-aspartate receptors.
2007,
Pubmed Bräuner-Osborne,
Ligands for glutamate receptors: design and therapeutic prospects.
2000,
Pubmed Chatterton,
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
2002,
Pubmed
,
Xenbase Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed Danysz,
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.
1998,
Pubmed Emsley,
Features and development of Coot.
2010,
Pubmed Erreger,
Glutamate receptor gating.
2004,
Pubmed Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed Gellért,
Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia.
2011,
Pubmed Grimwood,
Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.
1992,
Pubmed Hayward,
Systematic analysis of domain motions in proteins from conformational change: new results on citrate synthase and T4 lysozyme.
1998,
Pubmed Hess,
Functional characterization of human N-methyl-D-aspartate subtype 1A/2D receptors.
1998,
Pubmed
,
Xenbase Hollmann,
Cloned glutamate receptors.
1994,
Pubmed Huang,
Searching for presynaptic NMDA receptors in the nucleus accumbens.
2011,
Pubmed Jansen,
Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.
2003,
Pubmed Kalia,
NMDA receptors in clinical neurology: excitatory times ahead.
2008,
Pubmed Kasper,
The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)-glutamate and the antagonist (S)-NS1209.
2006,
Pubmed Kenny,
The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.
2009,
Pubmed Kleckner,
Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.
1988,
Pubmed
,
Xenbase Kvist,
Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase Langer,
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7.
2008,
Pubmed Laube,
Evidence for a tetrameric structure of recombinant NMDA receptors.
1998,
Pubmed
,
Xenbase Leeson,
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.
1994,
Pubmed Leeson,
4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.
1992,
Pubmed Leeson,
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.
1991,
Pubmed Lisman,
Long-term potentiation: outstanding questions and attempted synthesis.
2003,
Pubmed Madry,
Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
2007,
Pubmed
,
Xenbase Moriarty,
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation.
2009,
Pubmed Nacher,
The role of N-methyl-D-asparate receptors in neurogenesis.
2006,
Pubmed Nielsen,
Pharmacological properties of homomeric and heteromeric GluR1o and GluR3o receptors.
1998,
Pubmed
,
Xenbase Nilsson,
Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
2007,
Pubmed Paas,
The macro- and microarchitectures of the ligand-binding domain of glutamate receptors.
1998,
Pubmed Piña-Crespo,
Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits.
2010,
Pubmed Ransom,
Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines.
1988,
Pubmed Schüttelkopf,
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
2004,
Pubmed Sobolevsky,
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor.
2009,
Pubmed Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed Waxman,
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
2005,
Pubmed Yao,
Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A.
2006,
Pubmed Yao,
Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors.
2008,
Pubmed
